USE OF LACTOSUERO PERMEADO FOR THE TREATMENT OF METABOLIC SYNDROME

摘要

Use of permeate of sweet lactoserum with reduced lactose content partially hydrolyzed for the production of a pharmaceutical composition for the prophylaxis or treatment of symptoms of metabolic syndrome or type 2 diabetes, selecting the symptoms of glucose intolerance or resistance to insulin, and no calcium lactate being added to the pharmaceutical composition.